Hostname: page-component-cd9895bd7-gxg78 Total loading time: 0 Render date: 2024-12-22T23:15:50.966Z Has data issue: false hasContentIssue false
  • English
  • Français

Universal Admission Screening for Methicillin-Resistant Staphylococcus aureus in a Level HID Neonatal Intensive Care Unit: The First 9 Months

Part of: BARRY FARR AWARD RECIPIENTS

Published online by Cambridge University Press:  02 January 2015

Patrick J. Myers ,
John Marcinak ,
Michael Z. David ,
Diana L. Zychowski ,
Susan Boyle-Vavra ,
Stephen Weber  and
Robert S. Daum
Patrick J. Myers
Affiliation:
Section of Neonatology, Department of Pediatrics, University of Chicago, Chicago, Illinois
John Marcinak
Affiliation:
Section of Infectious Diseases, Department of Pediatrics, University of Chicago, Chicago, Illinois
Michael Z. David
Affiliation:
Section of Infectious Diseases and Global Health, Department of Medicine, University of Chicago, Chicago, Illinois
Diana L. Zychowski
Affiliation:
Section of Infectious Diseases, Department of Pediatrics, University of Chicago, Chicago, Illinois
Susan Boyle-Vavra
Affiliation:
Section of Infectious Diseases, Department of Pediatrics, University of Chicago, Chicago, Illinois
Stephen Weber
Affiliation:
Section of Infectious Diseases and Global Health, Department of Medicine, University of Chicago, Chicago, Illinois
Robert S. Daum*
Affiliation:
Section of Infectious Diseases, Department of Pediatrics, University of Chicago, Chicago, Illinois
*
University of Chicago Medical Center, 5841 South Maryland Avenue, MC 6054 Chicago, IL 60637 ([email protected])
Get access Rights & Permissions [Opens in a new window]

Extract

In response to epidemic methicillin-resistant Staphylococcus aureus (MRSA) in the community, the Illinois General Assembly mandated that all patients admitted to intensive care units statewide be screened for MRSA. Screening was instituted at our neonatal intensive care unit (NICU) in September 2007 by a polymerase chain reaction (PCR)-based strategy. The law created an opportunity to determine the rate of MRSA colonization among neonates, to gather information about subsequent MRSA infections, and to evaluate risk factors for MRSA colonization on admission to the NICU.

Type
Research Briefs
Information
Infection Control & Hospital Epidemiology , Volume 32 , Issue 4 , April 2011 , pp. 398 - 400
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

a.

Takeda Global Research and Development, Deerfield, Illinois

References

1. Stark, AR. Levels of neonatal care. Pediatrics 2004;114(5):1341–1347.Google Scholar
2. Kim, YH, Chang, SS, Kim, YS, et al. Clinical outcomes in meth-icillin-resistant Staphylococcus aureus-colonized neonates in the neonatal intensive care unit. Neonatology 2007;91(4):241–247.Google Scholar
3. Gregory, ML, Eichenwald, EC, Puopolo, KM. Seven-year experience with a surveillance program to reduce methicillin-resistant Staphylococcus aureus colonization in a neonatal intensive care unit. Pediatrics 2009;123(5):e790–e796.Google Scholar
4. Sarda, V, Molloy, A, Kadkol, S, Janda, WM, Hershow, R, McGuinn, M. Active surveillance for methicillin-resistant Staphylococcus aureus in the neonatal intensive care unit. Infect Control Hosp Epidemiol 2009;30(10):1029.Google Scholar